
The main Hepatitis B virus (HBV) mutants resistant to nucleoside analogs are susceptible in vitro to non-nucleoside inhibitors of HBV replication
Keywords: HBV, hepatitis B virus; NA, nucleos(t)ide; HAP, heteroaryldihydropyrimidineHBV; Nucleos(t)ide analog; Drug resistance; Non-nucleos(t)idic inhibitors; Nucleocapsid